TTTY23B

Across TCGA pan-cancer cohorts, TTTY23B RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated TTTY23B data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher TTTY23B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TTTY23B expression acts as an unfavorable survival marker, although some lineages such as LGG and BLCA show a favorable association.

ACC, DLBC, and LUAD are the cancer types where TTTY23B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	36	view →
LUAD	OS	Tertile	III,IV	0.068	0.680	<.001	36	view →
LGG	DFS	Tertile	All	0.948	0.799	.004	30	view →
SKCM	DFS	Tertile	All	0.058	0.757	<.001	27	view →
BLCA	DFS	Tertile	All	0.511	0.344	.023	24	view →
MESO	DFS	Tertile	IV	0.132	0.405	.041	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

TTTY23B–ACC (OS)

Open the ACC breakdown →